🇺🇸 FDA
Patent

US 8771706

Anti-RSV immunogens and methods of immunization

granted A61KA61K2039/5252A61K2039/545

Quick answer

US patent 8771706 (Anti-RSV immunogens and methods of immunization) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/5252, A61K2039/545, A61K2039/555, A61K2039/55505